The Expert Committee on Health Technology Assessment has begun work at the Center. With the support of the Agency for Methodological and Scientific-Practical Work, training was provided for Committee members. It focused on regulatory and procedural matters concerning the review of draft opinions of the authorized HTA body submitted to the Committee.
The event took place online under the guidance of Acting Director, Candidate of Pharmaceutical Sciences Yevheniia Ishkova, and the Head of the Agency, Doctor of Pharmaceutical Sciences, Professor Oleksandr Hudzenko.
The training was conducted by specialists of the Health Technology Assessment Department, led by Deputy Director of the Department Yuliia Malyshevska.
Addressing the training participants, Yevheniia Ishkova welcomed everyone to the start of the work and called for cooperation. “For patients, it is important to receive high-quality, safe and effective medicines, and for the state – to ensure treatment with the best effectiveness and cost-effectiveness.
I am confident that along this path we will be able to demonstrate close interaction and effective cooperation," she stressed. Yevheniia Ishkova also assured that the Center will continue to provide the Committee members with the necessary advisory, methodological, and educational assistance.
As a reminder, the main tasks of the HTA Expert Committee are:
- review of draft HTA conclusions;
- working through issues related to including medicinal products in the National List and the procedures for managed access agreements;
- preparation of reports, recommendations for draft HTA conclusions, and other issues.
